P3 Health Partners Inc Class A PIII
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PIII is a good fit for your portfolio.
News
-
P3 Health Partners Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
P3 Health Partners Names Dr. Aric Coffman as CEO
-
P3 Health Partners Announces First Quarter 2024 Results
-
P3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference Call
-
P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference
-
P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results
-
P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
-
P3 Health Partners to Present at the KeyBanc LifeSciences & Medtech Investor Forum
Trading Information
- Previous Close Price
- $0.55
- Day Range
- $0.52–0.53
- 52-Week Range
- $0.44–5.55
- Bid/Ask
- $0.52 / $0.52
- Market Cap
- $62.24 Mil
- Volume/Avg
- 38,068 / 359,422
Key Statistics
- Price/Earnings (Normalized)
- 0.07
- Price/Sales
- 0.13
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Value
- Total Number of Employees
- 400
- Website
- https://www.p3hp.org
Comparables
Valuation
Metric
|
PIII
|
AGL
|
ASTH
|
---|---|---|---|
Price/Earnings (Normalized) | 0.07 | — | 26.60 |
Price/Book Value | 0.45 | 3.19 | 2.84 |
Price/Sales | 0.13 | 0.46 | 1.27 |
Price/Cash Flow | — | — | 19.63 |
Price/Earnings
PIII
AGL
ASTH
Financial Strength
Metric
|
PIII
|
AGL
|
ASTH
|
---|---|---|---|
Quick Ratio | 0.53 | 1.30 | 2.03 |
Current Ratio | 0.55 | 1.33 | 2.11 |
Interest Coverage | −10.49 | −31.07 | 5.70 |
Quick Ratio
PIII
AGL
ASTH
Profitability
Metric
|
PIII
|
AGL
|
ASTH
|
---|---|---|---|
Return on Assets (Normalized) | −20.64% | −6.93% | 7.21% |
Return on Equity (Normalized) | −461.86% | −17.98% | 12.69% |
Return on Invested Capital (Normalized) | −29.07% | −16.40% | 9.69% |
Return on Assets
PIII
AGL
ASTH
Medical Care Facilities Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
HCA
| HCA Healthcare Inc | Cflfvbcnz | Ypqgqf | $85.1 Bil | |
FSNUY
| Fresenius SE & Co KGaA ADR | — | Dtdswx | $17.0 Bil | |
FSNUF
| Fresenius SE & Co KGaA | — | Khxqk | $17.0 Bil | |
FMS
| Fresenius Medical Care AG ADR | Gmcp | Pblyct | $12.9 Bil | |
FMCQF
| Fresenius Medical Care AG | — | Rbzhqh | $12.9 Bil | |
BDUUY
| Bangkok Dusit Medical Services PCL ADR | — | Cszkg | $12.9 Bil | |
BDUUF
| Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt | — | Tvpr | $12.9 Bil | |
THC
| Tenet Healthcare Corp | Tppvryzz | Kmx | $12.5 Bil | |
DVA
| DaVita Inc | Tqnmfcf | Nyflk | $12.4 Bil | |
AMN
| AMN Healthcare Services Inc | Ksxtwlqv | Nvwrwc | $2.3 Bil |